Edition:
India

Immutep Ltd (IMMP.OQ)

IMMP.OQ on NASDAQ Stock Exchange Global Market

2.38USD
22 Jun 2018
Change (% chg)

-- (--)
Prev Close
$2.38
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
12,122
52-wk High
$3.06
52-wk Low
$1.25

Latest Key Developments (Source: Significant Developments)

Immutep Ltd Enters Into Clinical Trial Collaboration With Merck & Co
Monday, 12 Mar 2018 

March 12 (Reuters) - Immutep Ltd ::ENTERED INTO A CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT WITH MERCK & CO., INC.DEAL TO EVALUATE COMBINATION OF IMMUTEP'S IMMUNOTHERAPY PRODUCT CANDIDATE WITH MSD'S ANTI-PD-1 THERAPY KEYTRUDA IN A NEW CLINICAL TRIAL.  Full Article

Prima Biomed says Lucy Turnbull steps down as chairman​
Friday, 17 Nov 2017 

Nov 17 (Reuters) - Prima Biomed Ltd ::Russell Howard appointed as chairman​.Lucy Turnbull steps down as chairman​.‍vice-Chairman Albert Wong to step down​.  Full Article

Prima Biomed files for offer and sale of up to 197.35 mln ordinary shares
Friday, 20 Oct 2017 

Oct 20 (Reuters) - Prima Biomed Ltd :Prima Biomed Ltd files for offer and sale of up to 197.35 million ordinary shares, represented by 1.97 million adss‍​ by selling shareholders - SEC filing.  Full Article

Prima Biomed ‍received approval for intiation of ‘Insight’ clinical trial
Monday, 10 Jul 2017 

July 10 (Reuters) - Prima Biomed Ltd :Received regulatory and ethical approvals for clinical trial investigating IMP321 in new settings, called Insight​.Approval has been received from Paul-Ehrlich-Institut, Federal Institute For Vaccines And Biomedicines For German Federal Ministry Of Health.  Full Article